aflatoxin B1 exo-8,9-epoxide

(6aS,7aS,8aR,8bR)-4-methoxy-2,3,6a,7a,8a,8b-hexahydrocyclopenta[c]oxireno[4',5']furo[3',2':4,5]furo[2,3-h]chromene-1,10-dione

KHBXRZGALJGBPA-IRWJRLHMSA-N CHEBI:30725 8 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

8 Reactome pathways

Metabolite details

Identifier: KHBXRZGALJGBPA-IRWJRLHMSA-N
InChI Key: KHBXRZGALJGBPA-IRWJRLHMSA-N
IUPAC name: (6aS,7aS,8aR,8bR)-4-methoxy-2,3,6a,7a,8a,8b-hexahydrocyclopenta[c]oxireno[4',5']furo[3',2':4,5]furo[2,3-h]chromene-1,10-dione
Preferred name: aflatoxin B1 exo-8,9-epoxide
INN name: —
Synonym: Aflatoxin B1 exo-8,9-oxide
ChEBI: CHEBI:30725

Reactome pathways

R-HSA-1430728 - Metabolism
R-HSA-156580 - Phase II - Conjugation of compounds
R-HSA-156590 - Glutathione conjugation
R-HSA-211859 - Biological oxidations
R-HSA-211897 - Cytochrome P450 - arranged by substrate type
R-HSA-211945 - Phase I - Functionalization of compounds
R-HSA-211981 - Xenobiotics
R-HSA-5423646 - Aflatoxin activation and detoxification

Observed in studies

Observed in differential profiles